“Deucravacitinib Improves Psoriasis Symptoms and Signs Diary Domain Scores in Patients With Moderate to Severe Plaque Psoriasis: Results From the Phase 3 POETYK PSO-1 and POETYK PSO-2 Studies”. SKIN The Journal of Cutaneous Medicine, vol. 5, no. 6, Nov. 2021, p. s38, https://doi.org/10.25251/skin.5.supp.38.